How does vitamin D supplementation affect benign paroxysmal positional vertigo intensity. What are the key findings of the longitudinal clinical study on vitamin D and BPPV. How can vitamin D deficiency impact vestibular function and balance in older adults. What are the potential mechanisms linking vitamin D to BPPV symptoms and recurrence.

The Link Between Vitamin D Deficiency and Benign Paroxysmal Positional Vertigo

Benign paroxysmal positional vertigo (BPPV) is a common vestibular disorder characterized by brief episodes of vertigo triggered by changes in head position. Recent research has shed light on the potential connection between vitamin D deficiency and BPPV, suggesting that supplementation may play a role in managing this condition.

A longitudinal clinical study examined the influence of supplemental vitamin D on the intensity of BPPV symptoms. The findings indicate a significant relationship between vitamin D levels and the severity and recurrence of BPPV episodes.

Prevalence of Vitamin D Deficiency in BPPV Patients

Studies have shown a higher prevalence of vitamin D deficiency among patients with BPPV compared to the general population. Can this be merely coincidental? Evidence suggests otherwise. A study by Jeong et al. found decreased serum vitamin D levels in patients with idiopathic BPPV, indicating a potential causal relationship.

Mechanisms of Vitamin D’s Impact on Vestibular Function

How does vitamin D influence the vestibular system? The mechanisms are multifaceted:

• Calcium metabolism regulation: Vitamin D plays a crucial role in calcium homeostasis, which is essential for proper otolith function in the inner ear.
• Muscle strength and balance: Vitamin D deficiency can lead to decreased muscle strength and impaired balance, potentially exacerbating BPPV symptoms.
• Neuroprotective effects: Vitamin D has been shown to have neuroprotective properties, which may extend to the vestibular system.

Clinical Outcomes of Vitamin D Supplementation in BPPV Patients

The longitudinal study revealed promising results regarding the effects of vitamin D supplementation on BPPV symptoms. Patients receiving vitamin D supplements experienced:

1. Reduced intensity of vertigo episodes
2. Decreased frequency of BPPV recurrence
3. Improved quality of life scores

These findings suggest that addressing vitamin D deficiency may be an effective adjunct therapy in managing BPPV.

Vitamin D Supplementation and Fall Prevention in Older Adults

Beyond its effects on BPPV, vitamin D supplementation has been associated with fall prevention in older adults. Is there a connection between these benefits and BPPV management? Research indicates that improved muscle strength and balance resulting from adequate vitamin D levels may contribute to both fall prevention and reduced BPPV symptoms.

Optimal Dosage and Duration of Vitamin D Supplementation

Determining the ideal vitamin D supplementation regimen for BPPV patients is crucial. While the optimal dosage may vary depending on individual factors, studies suggest that achieving and maintaining sufficient serum vitamin D levels is key to maximizing benefits.

Combining Vitamin D Supplementation with Traditional BPPV Treatments

How does vitamin D supplementation complement existing BPPV treatments? The Epley maneuver and other canalith repositioning techniques remain the gold standard for acute BPPV management. However, vitamin D supplementation may enhance the effectiveness of these treatments and reduce the likelihood of recurrence.

Potential Synergistic Effects

Combining vitamin D supplementation with traditional BPPV treatments may offer synergistic benefits:

• Improved otolith stability due to enhanced calcium metabolism
• Faster recovery and reduced symptom intensity following repositioning maneuvers
• Lower recurrence rates in the long term

The Role of Vitamin D in Other Vestibular Disorders

While the focus of this study is on BPPV, the potential impact of vitamin D on other vestibular disorders should not be overlooked. Could vitamin D deficiency play a role in conditions such as Ménière’s disease or vestibular neuritis? Further research is needed to explore these possibilities and determine if vitamin D supplementation could benefit a broader range of vestibular patients.

Implications for Clinical Practice and Future Research

The findings of this longitudinal study have significant implications for the management of BPPV and potentially other vestibular disorders. What changes in clinical practice might result from this research?

• Routine screening for vitamin D deficiency in BPPV patients
• Integration of vitamin D supplementation into BPPV treatment protocols
• Increased focus on nutritional factors in vestibular health

Future research directions may include:

1. Large-scale randomized controlled trials to further validate the effects of vitamin D supplementation on BPPV
2. Investigation of the potential benefits of vitamin D in other vestibular disorders
3. Exploration of the molecular mechanisms underlying the relationship between vitamin D and vestibular function

Addressing Vitamin D Deficiency in the General Population

The high prevalence of vitamin D deficiency, particularly in certain populations, raises questions about broader public health implications. Could addressing vitamin D deficiency on a population level lead to a reduction in BPPV incidence? While more research is needed, the potential benefits extend beyond vestibular health to include improved musculoskeletal function and reduced risk of falls in older adults.

Risk Factors for Vitamin D Deficiency

Understanding the risk factors for vitamin D deficiency is crucial for identifying individuals who may benefit from supplementation. Common risk factors include:

• Limited sun exposure
• Darker skin pigmentation
• Obesity
• Certain medical conditions affecting vitamin D metabolism
• Age-related decreases in vitamin D synthesis and absorption

The Interplay Between Vitamin D, Calcium, and Vestibular Health

Vitamin D’s role in calcium metabolism is well-established, but how does this relate to vestibular function? The otoconia, small calcium carbonate crystals in the inner ear, play a crucial role in balance and spatial orientation. Proper calcium metabolism, facilitated by adequate vitamin D levels, is essential for the formation and maintenance of these structures.

Calcium Homeostasis and Otoconia

The relationship between calcium homeostasis and otoconia health is complex:

• Vitamin D promotes calcium absorption in the intestines
• It regulates calcium levels in the blood and extracellular fluid
• Adequate calcium levels are necessary for proper otoconia formation and stability
• Imbalances in calcium metabolism may contribute to otoconia degradation or displacement

By ensuring proper vitamin D levels, we may be able to maintain optimal calcium homeostasis and support the health of the vestibular system.

Seasonal Variations in Vitamin D Levels and BPPV Incidence

An interesting aspect of vitamin D research is the observation of seasonal variations in serum levels. Do these fluctuations correlate with changes in BPPV incidence or severity? Some studies have reported higher rates of BPPV during winter months when vitamin D levels tend to be lower due to reduced sun exposure.

Implications for BPPV Management

Understanding seasonal patterns in vitamin D levels and BPPV incidence could have practical implications for patient care:

• Increased vigilance for BPPV symptoms during winter months
• Consideration of prophylactic vitamin D supplementation during periods of lower sun exposure
• Patient education on the importance of maintaining adequate vitamin D levels year-round

Vitamin D Supplementation in Different Age Groups

While BPPV is more common in older adults, it can affect individuals of all ages. How does the impact of vitamin D supplementation vary across different age groups? The longitudinal study provides insights into this question, but further research is needed to fully understand age-related differences in response to vitamin D supplementation for BPPV management.

Considerations for Pediatric and Geriatric Populations

Age-specific factors to consider in vitamin D supplementation for BPPV include:

• Differences in vitamin D metabolism and absorption
• Varying risk factors for vitamin D deficiency
• Potential interactions with other age-related health conditions
• Dosage adjustments based on age and body weight

The Economic Impact of Vitamin D Supplementation in BPPV Management

Beyond the clinical benefits, what are the potential economic implications of incorporating vitamin D supplementation into BPPV treatment protocols? While the cost of supplementation must be considered, the potential savings from reduced healthcare utilization and improved quality of life could be substantial.

Cost-Effectiveness Analysis

Factors to consider in evaluating the cost-effectiveness of vitamin D supplementation for BPPV include:

• Reduced frequency of medical visits for BPPV episodes
• Decreased need for diagnostic tests and imaging studies
• Lower incidence of falls and related injuries
• Improved workplace productivity due to reduced vertigo symptoms

A comprehensive cost-effectiveness analysis could help inform policy decisions regarding the implementation of vitamin D supplementation strategies for BPPV management.

Integrating Vitamin D Assessment into Vestibular Evaluation Protocols

Given the growing evidence linking vitamin D deficiency to BPPV and other vestibular disorders, should vitamin D assessment become a standard part of vestibular evaluation protocols? Integrating vitamin D testing into routine vestibular workups could provide valuable information for diagnosis and treatment planning.

Potential Benefits of Routine Vitamin D Assessment

• Early identification of vitamin D deficiency in vestibular patients
• Personalized treatment plans incorporating vitamin D supplementation when appropriate
• Improved understanding of the relationship between vitamin D status and vestibular function
• Opportunity for patient education on the importance of vitamin D in overall health

By incorporating vitamin D assessment into vestibular evaluations, clinicians may be able to provide more comprehensive care and potentially improve outcomes for patients with BPPV and other vestibular disorders.

The Role of Vitamin D in Vestibular Rehabilitation

Vestibular rehabilitation is a key component of BPPV management, particularly for patients with persistent symptoms or frequent recurrences. How might vitamin D supplementation enhance the effectiveness of vestibular rehabilitation exercises? The potential synergistic effects of combining vitamin D supplementation with vestibular rehabilitation warrant further investigation.

Potential Mechanisms of Synergy

Several factors may contribute to the potential benefits of combining vitamin D supplementation with vestibular rehabilitation:

• Improved muscle strength and endurance, facilitating better performance of rehabilitation exercises
• Enhanced proprioception and balance, potentially accelerating the adaptation process
• Neuroprotective effects of vitamin D supporting neural plasticity during rehabilitation
• Reduced inflammation and oxidative stress, creating a more favorable environment for recovery

Future studies examining the combined effects of vitamin D supplementation and vestibular rehabilitation could provide valuable insights for optimizing BPPV treatment protocols.

Genetic Factors Influencing Vitamin D Metabolism and BPPV Susceptibility

The relationship between vitamin D and BPPV may be influenced by genetic factors. Do variations in genes involved in vitamin D metabolism affect an individual’s susceptibility to BPPV or their response to vitamin D supplementation? Exploring the genetic underpinnings of this relationship could lead to more personalized approaches to BPPV prevention and treatment.

Potential Genetic Markers

Several genetic factors may play a role in the vitamin D-BPPV connection:

• Polymorphisms in vitamin D receptor genes
• Variations in genes involved in vitamin D synthesis and activation
• Genetic factors affecting calcium metabolism and otoconia formation
• Inherited susceptibilities to vestibular disorders

Future research incorporating genetic analysis could help identify individuals at higher risk for vitamin D-related BPPV and guide targeted intervention strategies.

Long-Term Effects of Vitamin D Supplementation on Vestibular Health

While the longitudinal study provides valuable insights into the short-term effects of vitamin D supplementation on BPPV, questions remain about the long-term impact on overall vestibular health. What are the potential benefits and risks of prolonged vitamin D supplementation for individuals with recurrent BPPV or other vestibular disorders?

Areas for Long-Term Investigation

Future studies examining the long-term effects of vitamin D supplementation should consider:

• Changes in vestibular function and balance over extended periods
• Incidence of other vestibular disorders in individuals receiving long-term vitamin D supplementation
• Potential protective effects against age-related vestibular degeneration
• Safety and efficacy of different dosing regimens for long-term use

Understanding the long-term implications of vitamin D supplementation could inform strategies for maintaining vestibular health throughout the lifespan.

Influence of supplemental vitamin D on intensity of benign paroxysmal positional vertigo: A longitudinal clinical study

1. Heidari B, Heidari P, Samari E, Jalali MR. Frequency of vitamin D deficiency in common musculoskeletal conditions. J Babol Univ Med Sci. 2014;16:7–15. [in Persian] [Google Scholar]

2. Heidari B, Heidari P, Hajian-Tilaki K. High prevalence of vitamin D deficiency in women presenting to rheumatology clinic in north of Iran: An inverse relation with age. J Women’s Health Care. 2013;2:123. [Google Scholar]

3. Heidari B. Knee osteoarthritis prevalence, risk factors, pathogenesis and features: Part I. Caspian J Intern Med. 2011;2:205–12. [PMC free article] [PubMed] [Google Scholar]

4. Heidari B. Muscle strength, vitamin D deficiency and knee osteoarthritis. J Babol Univ Med Sci. 2012;14:84–91. [Google Scholar]

5. Heidari B. Knee osteoarthritis diagnosis, treatment and associated factors of progression: Part II. Casp J Intern Med. 2011;2:249–55. [PMC free article] [PubMed] [Google Scholar]

6. Heidari B, Heidari P, Tilaki KH. Relationship between unexplained arthralgia and vitamin D deficiency: a case control study. Acta Med Iran. 2014;52:400–5. [PubMed] [Google Scholar]

7. Heidari B, Javadian Y, Babaei M, Yousef Ghahari B. Restorative effect of vitamin D deficiency on knee pain and quadriceps muscle strength in knee osteoarthritis. Acta Med Iran. 2015;53:460–70. [PubMed] [Google Scholar]

8. Heidari B, Monadi M, Asgharpour M, et al. Efficiency of supplemental vitamin D in patients with chronic obstructive pulmonary disease. Br J Med Med Res. 2014;4:3031–41. [Google Scholar]

9. Silva C, Amorim AM, Paiva A. Benign paroxysmal positional vertigo–a review of 101 cases. Acta Otorrinolaringol Esp. 2015;66:205–9. [PubMed] [Google Scholar]

10. Lopez-Escamez JA, Gamiz MJ, Fernandez-Perez A, Gomez-Fiñana M. Long-term outcome and health-related quality of life in benign paroxysmal positional vertigo. Eur Arch Otorhinolaryngol. 2005;262:507–11. [PubMed] [Google Scholar]

11. Iwasaki S, Yamasoba T. Dizziness and Imbalance in the Elderly: Age-related Decline in the Vestibular System. Aging Dis. 2014;6:38–47. [PMC free article] [PubMed] [Google Scholar]

12. Rejnmark L. Effects of vitamin D on muscle function and performance: a review of evidence from randomized controlled trials. Ther Adv Chronic Dis. 2011;2:25–37. [PMC free article] [PubMed] [Google Scholar]

13. Muir SW, Montero-Odasso M. Effect of vitamin D supplementation on muscle strength, gait and balance in older adults: a systematic review and meta-analysis. J Am Geriatr Soc. 2011;59:2291–300. [PubMed] [Google Scholar]

14. Hilton M, Pinder D. The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo. Cochrane Database Syst Rev. 2004;2:CD003162. [PubMed] [Google Scholar]

15. Nunez RA, Cass SP, Furman JM. Short- and long-termoutcomes of canalith repositioning for benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg. 2000;122:647–52. [PubMed] [Google Scholar]

16. West N, Hansen S, Møller MN, Bloch SL, Klokker M. Repositioning chairs in benign paroxysmal positional vertigo: implications and clinical outcome. Eur Arch Otorhinolaryngol. 2015 Mar 7; [Epub ahead of print] [PubMed] [Google Scholar]

17. Heidari B, Haji Mirghassemi MB. Seasonal variations in serum vitamin D according to age and sex. Caspian J Intern Med. 2012;3:535–40. [PMC free article] [PubMed] [Google Scholar]

18. Talaat HS, Kabel AH, Khaliel LH, Abuhadied G, El-Naga HA, Talaat AS. Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency. Auris Nasus Larynx. 2015 Sep 16; pii: S0385-8146(15)00203-5. doi: 10.1016/j.anl.2015.08.009. [Epub ahead of print] [PubMed] [Google Scholar]

19. Jeong SH, Kim JS, Shin JW, et al. Decreased serum vitamin D in idiopathic benign paroxysmal positional vertigo. J Neurol. 2013;260:832–8. [PubMed] [Google Scholar]

20. Suzuki T. Frontiers in vitamin D; basic research and clinical application Vitamin D and falls. Clin Calcium. 2011;21:71–9. [PubMed] [Google Scholar]

21. Mastaglia SR, Seijo M, Muzio D, et al. Effect of vitamin D nutritional status on muscle function and strength in healthy women aged over sixty-five years. J Nutr Health Aging. 2011;15:349–54. [PubMed] [Google Scholar]

22. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: A meta-analysis of randomised controlled trials. BMJ. 2009;339:b3692. [PMC free article] [PubMed] [Google Scholar]

23. Boersma D, Demontiero O, Mohtasham Amiri Z, et al. Vitamin D status in relation to postural stability in the elderly. J Nutr Health Aging. 2012;16:270–5. [PubMed] [Google Scholar]

24. Cangussu LM, Nahas-Neto J, Orsatti CL, et al. Effect of isolated vitamin D supplementation on the rate of falls and postural balance in postmenopausal women fallers: a randomized, double-blind, placebo-controlled trial. Menopause. 2015 Nov 2; [Epub ahead of print] [PubMed] [Google Scholar]

25. Parham K, Leonard G, Feinn RS, et al. Prospective clinical investigation of the relationship between idiopathic benign paroxysmal positional vertigo and bone turnover: a pilot study. Laryngoscope. 2013;123:2834–9. [PubMed] [Google Scholar]

26. Talaat HS, Abuhadied G, Talaat AS, Abdelaal MS. Low bone mineral density and vitamin D deficiency in patients with benign positional paroxysmal vertigo. Eur Arch Otorhinolaryngol. 2015;272:2249–53. [PubMed] [Google Scholar]

27. Yu S, Liu F, Cheng Z, Wang Q. Association between osteoporosis and benign paroxysmal positional vertigo: a systematic review. BMC Neurol. 2014;14:110. [PMC free article] [PubMed] [Google Scholar]

28. Heidari B, Heidari P, Nourooddini HG, Hajian-Tilaki KO. Relationship between parity and bone mass in postmenopausal women according to number of parities and age. J Reprod Med. 2013;58:389–94. [PubMed] [Google Scholar]

29. Heidari B, Hoshmand S, Hajian K, Heidari P. Comparing bone mineral density in postmenopausal women with and without vertebral fracture and its value in recognizing high-risk individuals. East Mediterr Health J. 2010;16:868–73. [PubMed] [Google Scholar]

30. Heidari B, Javadian Y, Monadi M, Dankob Y, Firouzjahi A. Vitamin D status and distribution in patients with chronic obstructive pulmonary disease versus healthy controls. Caspian J Intern Med. 2015;6:93–7. [PMC free article] [PubMed] [Google Scholar]

31. Hajian-Tilaki K, Heidari B, Firouzjahi A, et al. Prevalence of metabolic syndrome and the association with socio-demographic characteristics and physical activity in urban population of Iranian adults: a population-based study. Diabetes Metab Syndr. 2014;8:170–6. [PubMed] [Google Scholar]

32. Prasad P, Kochhar A. Interplay of vitamin D and metabolic syndrome: A review. Diabetes Metab Syndr. 2015 Mar 6; pii: S1871-4021(15)00027-2. doi: 10.1016/j.dsx.2015 .02.014. [Epub ahead of print] [PubMed] [Google Scholar]

33. Hajian-Tilaki K, Heidari B. Prevalence of obesity, central obesity and the associated factors in urban population aged 20-70 years, in the north of Iran: a population-based study and regression approach. Obes Rev. 2007;8:3–10. [PubMed] [Google Scholar]

34. Hajian-Tilaki K, Heidari B. Childhood obesity, overweight, sociodemographic and life style determinants among preschool children in Babol, Northern Iran. Iran Public Health. 2013;42:1283–91. [PMC free article] [PubMed] [Google Scholar]

35. Hajian-Tilaki K, Heidari B. Prevalence of overweight and obesity and their association with physical activity pattern among Iranian adolescents aged 12-17 years. Public Health Nutr. 2012;15:2246–52. [PMC free article] [PubMed] [Google Scholar]

36. Waringhoff JC, Bayer O, Ferrari U, Straube A. Co-morbidities of vertiginous disease. BMC Neurol. 2009;9:29. [PMC free article] [PubMed] [Google Scholar]

37. Yamanka T, Fukuda T, Shirota S, et al. The prevalence and characteristics of metabolic syndrome in patients with vertigo. Plos One. 2013;8:e80176. [PMC free article] [PubMed] [Google Scholar]

Taking Vitamin D Twice a Day May Keep Vertigo Away

Research published August 2020 in Neurology, the journal of the American Academy of Neurology, describes the benefit of taking both vitamin D and calcium twice a day to decrease a recurrence of vertigo for individuals predisposed to experiencing this disconcerting and sometimes dangerous physiologic symptom.  

Ji-Soo Kim, MD, PhD, of Seoul National University College of Medicine in Korea and colleagues examined nearly 1,000 individuals in Korea who were diagnosed with benign paroxysmal positional vertigo and who were subsequently successfully treated with therapeutic head movements. The authors describe benign paroxysmal positional vertigo as one of the most common types of vertigo (or dizziness), occurring when the position of the head changes and results in a “sudden spinning sensation. ” Treatment involves performing a series of head movements that are intended to shift particles in the ears that cause the vertigo; however, despite initial improvement, vertigo frequently recurs. The authors note that roughly 86% of people with this form of vertigo miss days at work and find that it interrupts their daily life.

“Our study suggests that for people with benign paroxysmal positional vertigo, taking a supplement of vitamin D and calcium is a simple, low-risk way to prevent vertigo from recurring,” said Dr. Kim, who added, “It is especially effective if you have low vitamin D levels to begin with.”

The 348 people of the 445 in the intervention group had vitamin D levels below 20 nanograms per milliliter (ng/mL) and received vitamin D supplementation of 400 international units of vitamin D and 500 milligrams of calcium twice daily. The remainder had levels equal to or greater than 20 ng/mL and were not given supplements. The observation group included 512 people who did not receive supplements and did not have their vitamin D levels monitored. The authors wrote that the intervention group showed a reduction in the absolute risk reduction [0.83 (95% CI, 0.74-0.92) vs. 1.10 (95% CI, 1.00-1.19) recurrences per one-person year with an incidence rate ratio of 0.76 (95% CI, 0.66-0.87, P <.001) and an absolute rate ratio of -0.27 (-0.40 to -0.14) from intention to treat analysis. The number needed to treat was 3.70 (95% CI, 2.50-7.14). The proportion of patients with recurrence was also lower in the intervention than in the observation group (37.8 vs. 46.7%, P = .005).

“Our results are exciting because so far, going to the doctor to have them perform head movements has been the main way we treat benign paroxysmal positional vertigo,” said Dr. Kim. “Our study suggests an inexpensive, low-risk treatment like vitamin D and calcium tablets may be effective at preventing this common, and commonly recurring, disorder.”

The authors observed a greater improvement in vertigo for patients who exhibited a greater vitamin D deficiency at the beginning of the study, with individuals starting at a level lower than 10 ng/mL experiencing a 45% reduction in annual recurrence rate. Comparatively, individuals with levels between 10 and 20 ng/mL experienced only a 14% reduction. A total of 38% of the people in the interventional group had another episode of vertigo, compared with 47% of those in the observation group. The authors noted that many subjects dropped out of study before it was completed, a limitation to the trial.

The content contained in this article is for informational purposes only. The content is not intended to be a substitute for professional advice. Reliance on any information provided in this article is solely at your own risk.

 « Click here to return to Health Systems Update.

Vitamin D deficiency can cause dizziness attacks

• Health

To find out, Egyptian scientists conducted a study on 40 patients diagnosed with benign paroxysmal positional vertigo. Translated into human – dizzy with a sharp change in posture.

August 24, 2021

Source:

iStock/Getty Images

About 20 percent of adults complain of dizziness. Many of them are not due to problems with neurology, but with disorders in the vestibular apparatus. Calcium carbonate crystals (otoconia) enter the semicircular canals and cause benign paroxysmal positional vertigo (BPPV). It occurs most often due to a change in the position of the head, tilting, turning when you get out of bed or lie down in it. Therefore, the disease has another name – positional vertigo. It can be accompanied by mild nausea, even vomiting, and does not last long – a few minutes. Scientists have suggested that the process may be affected by a lack of vitamin D.

“We set out to evaluate the association between recurrent BPPV attacks and vitamin D deficiency,” Aida Ahmed Abdelmaqsoud, co-author of the ENT department at the University of the South Valley School of Medicine, Egypt, explained the purpose of the study in the journal Nature.

Read also

40 patients who had already been diagnosed with BPPV were selected for the study. All had low levels of vitamin D – this was a prerequisite for participation in the study. Among them were 14 men and 26 women, they were divided into two groups – receiving an additional dose of vitamin D, and those who were treated in the usual way. The therapy was repeated six months later. It was found that vitamin D directly affects the mechanism of formation of otoconial particles in the vestibular system.

“Vitamin D deficiency has been associated with BPPV severity and recurrence,” said Aida Ahmed Abdelmaqsoud. “And adding vitamin D to therapy may reduce the frequency of recurrent seizures.”

Adequate levels of vitamin D can be maintained through skin photosynthesis and oral intake. According to Egyptian scientists, about a billion people around the world suffer from a deficiency or lack of vitamin D even in summer: somewhere there is not enough sun, somewhere bad weather conditions, air pollution, too much sunscreen is used, clothes get dirty.

Text author:Alena Bezmenova

Today they read

Cardiologist Koliev named 4 habits that will not let you die of a heart attack in the prime of life

Reduce cholesterol and save from blood clots: 6 spices that every housewife should have

Personal experience : how to lower cholesterol by 35% without pills

Women over 40 are recommended to take these vitamins – the opinion of the gynecologist Volkova

Bad blood vessels and venous stasis: a vegetologist explained who suffers from stuffiness intolerance

Vitamin D and benign paroxysmal positional vertigo

PUBLICATIONS

Relevance

Benign paroxysmal positional vertigo (BPPV) is one of the most common diseases of the peripheral part of the vestibular analyzer. The main clinical manifestation of BPPV is intermittent short-term attacks of dizziness when the head position changes. It is believed that BPPV is the most common cause of dizziness (18-25% of all cases of dizziness).

Despite the benign nature of the disease, the presence of BPPV is associated with a decrease in the quality of life. However, there are no effective methods to prevent BPPV. Several observational studies have found that BPPV patients are more likely than the general population to have vitamin D deficiency and decreased bone mineral density. In this connection, the purpose of the study under discussion was to evaluate the effectiveness of vitamin D in the prevention of BPPV.

Methods

The randomized trial was performed in 8 hospitals in South Korea between December 2013 and May 2017.

Its participants were patients with BPPV. All of them were randomized into two groups: vitamin D therapy 400 IU in combination with 500 mg calcium carbonate twice a day (if the concentration of vitamin D was less than 20 ng/ml) and standard observation.

The primary end point was the annual recurrence rate. The mean follow-up period for participants was 1 year.

Results

• The study participants were 1050 patients with BPPV.

• It was found that, on average, during the study period, relapses of dizziness were observed with a frequency of 0.83 cases per year in the vitamin D group and 1.1 cases per year in the standard observation group (hazard ratio 0.76; 95% confidence interval 0.66-0.87; p<0.001. In addition , in the active therapy group, BPPV relapses were reported in fewer patients (37.8% vs. 46.7%; p=0.005).

• The estimated number of patients who needed to be treated with vitamin D to prevent recurrence of BPPV was 3.7 (95% CI 2.5-7.14).

Conclusion

Thus, the results of the present study demonstrate that in patients with BPPV, vitamin D and calcium supplementation reduces the frequency of relapses. Probably, their administration can be considered as a way to prevent dizziness in patients with calcium deficiency and frequent relapses of BPPV.